Cost-effectiveness of drug compliance in type 2 diabetes mellitus patients

dc.creatorMaciel, Olga
dc.creatorVera, Zully
dc.creatorMarín, Gustavo Horacio
dc.creatorMaidana, Mabel
dc.creatorSamaniego, Lourdes
dc.creatorLugo, Gladys
dc.creatorMastroianni, Patricia
dc.date2018-10
dc.date2020-07-01T17:27:33Z
dc.date.accessioned2023-07-14T20:08:31Z
dc.date.available2023-07-14T20:08:31Z
dc.identifierhttp://sedici.unlp.edu.ar/handle/10915/99653
dc.identifierhttps://ri.conicet.gov.ar/11336/84321
dc.identifierhttps://www.rjpbcs.com/pdf/2018_9(5)/[230].pdf
dc.identifierissn:0975-8585
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7438067
dc.descriptionType 2 diabetes mellitus affects 15% of the population around the world, causing health complications and increasing the treatment’s costs. Being a chronic outpatient treatment disease, patient compliance is higher importance to achieve therapeutic success. The present study measure the cost effectiveness of the compliance of this disease. An observational, cross-sectional, pharmaco-economic study was performed. A National program to stimulate treatment adherence was taken as intervention stage. Compliance was measure by Morisky-Green test and details of the events in each patient's health (medication, consultations, hospitalization and concomitant treatments) were used to determinate the direct costs for Ministry of Public Health. Effectiveness was measured by percentage of glycated hemoglobin (HbA1c). The sample obtained was 55 patients, which were grouped into 31 compliant and 24 non-compliant. The costeffectiveness of compliance was 466 US$ / compliant effective patient and 1,807 US$ / non-compliant effective patient. The cost-effectiveness of hypoglycemic drug therapy compliance is significantly lower (almost 4 times) than non-compliance. Type 2 Diabetes Mellitus patients that have no therapy adherence are not able to maintain protective levels of HbA1c. In addition, for the Ministry of Public Health, the lack of adherence requires more budget to accomplished the health goals.
dc.descriptionFacultad de Ciencias Médicas
dc.descriptionConsejo Nacional de Investigaciones Científicas y Técnicas
dc.formatapplication/pdf
dc.format1824-1829
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightsCreative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
dc.subjectMedicina
dc.subjectCost-effectiveness
dc.subjectType 2 diabetes
dc.subjectAdherence
dc.subjectPharmacotherapy compliance
dc.titleCost-effectiveness of drug compliance in type 2 diabetes mellitus patients
dc.typeArticulo
dc.typeArticulo


Este ítem pertenece a la siguiente institución